long covid

  1. Chandelier

    Persistent Sleep Disturbance Following Pandemic Lockdowns: Longitudinal Findings From the UK COVID ‐19 Symptom Study Biobank, 2026, Toson et al.

    Persistent Sleep Disturbance Following Pandemic Lockdowns: Longitudinal Findings From the UK COVID ‐19 Symptom Study Biobank ABSTRACT Sleep disturbance and fatigue were highly prevalent during the COVID-19 pandemic, in both infected and non-infected individuals, though mostly assessed...
  2. Chandelier

    Estimating the Quality-Adjusted Life-Year Loss due to Fatal & Nonfatal COVID-19 Outcomes across US States & Counties, Jul 20 to Dec 22, 2026, Mikdashi

    Estimating the Quality-Adjusted Life-Year Loss due to Fatal and Nonfatal COVID-19 Outcomes across US States and Counties, July 2020 to December 2022 Abstract Objective: The population-level quality-of-life impact of nonfatal health outcomes, including prolonged hospitalizations and long...
  3. Chandelier

    Post‐Omicron cognitive decline is largely reversible: Two‐year multicenter cohort study of domain‐specific outcomes in hospitalized patients, 2026,Qiu

    Post‐Omicron cognitive decline is largely reversible: Two‐year multicenter cohort study of domain‐specific outcomes in hospitalized patients Abstract Background Cognitive impairment represents a significant concern within the spectrum of post-acute sequelae of Severe Acute Respiratory...
  4. Chandelier

    COVID-19 vaccination timing, relative to acute COVID-19, and subsequent risk of long COVID, 2026, Butzin-Dozier et al.

    COVID-19 vaccination timing, relative to acute COVID-19, and subsequent risk of long COVID Summary Background Vaccination is a vital tool in preventing acute COVID-19 and may confer additional protection against Long COVID, although it is unclear whether this protection wanes over time...
  5. Chandelier

    IL-6 family cytokines behind acute COVID-19 and Long COVID syndrome: Mechanisms, biomarkers, and intervention strategies, 2026, Bustos et al.

    IL-6 family cytokines behind acute COVID-19 and Long COVID syndrome: Mechanisms, biomarkers, and intervention strategies Bustos, Matilde; Rodríguez-Hernández, María Ángeles Highlights IL-6 family cytokines differentially contribute to COVID-19 and Long COVID. Biomarker strength differs among...
  6. forestglip

    An exploratory exome-wide [ML] identifies candidate host gene signatures associated with [LC] in a large admixed Brazilian cohort, 2026, Zetum et al

    An exploratory exome-wide machine learning analysis identifies candidate host gene signatures associated with Long COVID in a large admixed Brazilian cohort Introduction Genetic factors have been suggested as modifiers of vulnerability to postCOVID-19 sequelae, referred to as Long COVID (LC)...
  7. Chandelier

    Item comprehension and content coverage of patient-reported outcome measures for long COVID: a qualitative study, 2026, Zigler et al.

    Item comprehension and content coverage of patient-reported outcome measures for long COVID: a qualitative study Abstract Purpose Fit-for-purpose clinical outcome assessments are essential to inform medical product development, but outcome measures for Long COVID, a new and devastating...
  8. Chandelier

    Necroptosis and Cellular Stress Characterize Immune and Endothelial Dysfunction in Long COVID, 2026, Dias et al.

    Necroptosis and Cellular Stress Characterize Immune and Endothelial Dysfunction in Long COVID Abstract Background Long COVID, or Post-Acute Sequelae of SARS-CoV-2 infection (PASC), affects a significant proportion of COVID-19 survivors and is associated with persistent fatigue, dysautonomia...
  9. Chandelier

    Persistent neurological and behavioral alterations after SARS-CoV-2 infection in an optimized K18-hACE2 mouse model, 2026, Ruiz-Casas et al.

    Persistent neurological and behavioral alterations after SARS-CoV-2 infection in an optimized K18-hACE2 mouse model Abstract Introduction: Persistent neurological symptoms are among the most prevalent and debilitating manifestations of post-COVID-19 Condition (PCC), affecting millions of...
  10. Chandelier

    Stress, social support, and long COVID diagnosis and symptom burden in women, 2026, Likhacheva et al.

    Stress, social support, and long COVID diagnosis and symptom burden in women. Abstract Objectives: To examine whether general stress and childcare stress are associated with long COVID status, symptom number, and symptom duration in women, and whether perceived and received social support...
  11. Chandelier

    Efficacy of a psychotherapeutic group intervention for patients with Post-COVID-19 condition: a [RCT] (PsyLoCo study), 2026, Rometsch et al.

    Efficacy of a psychotherapeutic group intervention for patients with Post-COVID-19 condition: a randomized controlled trial (PsyLoCo study) Abstract Background Persistent physical symptoms such as fatigue following SARS-CoV-2 infection are common and often accompanied by cognitive complaints...
  12. Chandelier

    Closed Complementary Self-help Strategies for Patients With Post-COVID-19 Syndrome (NASH-POCO), 2026, Haller, Kleinschnitz et al.

    https://clinicaltrials.gov/study/NCT05798221?id=NCT05798221&viewType=Card&rank=1&tab=study Complementary Self-help Strategies for Patients With Post-COVID-19 Syndrome (NASH-POCO) ClinicalTrials.gov ID: NCT05798221 Brief Summary Individuals affected by SARS-CoV-2 infection may subsequently be...
  13. N

    Plasma Cytokine and Caspase-1p20 Profiles in Pre-Pandemic and Long COVID-Associated Postural Orthostatic Tachycardia Syndrome, 2026, Gunning et al

    Background: Prior to the COVID-19 pandemic, the etiology of postural orthostatic tachycardia syndrome (POTS) remained elusive. Since the pandemic, a newly recognized disorder, termed Long COVID, has emerged with a significant subset of patients developing dysautonomia and a multitude of...
  14. Chandelier

    Evaluation of neuronal and immunological biomarkers in post-COVID-19 condition, 2026, de Souza Fonseca et al.

    Evaluation of neuronal and immunological biomarkers in post-COVID-19 condition Highlights Plasma biomarkers reveal persistent inflammation in post-COVID condition (PCC) volunteers. Volunteers with neurological symptoms PCC-NS showed high IgA levels. PCC-NS volunteers presented elevated...
  15. forestglip

    Review Systematic review of randomized clinical trials for the treatment of long COVID syndrome, 2026, Tamariz et al

    Systematic review of randomized clinical trials for the treatment of long COVID syndrome Background There is a critical need for interventions for long COVID. Our aim was to conduct a systematic review on the efficacy and safety of different interventions in patients with long COVID...
  16. Chandelier

    Neurologic Manifestations of Long COVID Affect Adult Females More Severely Than Males, 2026, Kopinsky et al.

    Neurologic Manifestations of Long COVID Affect Adult Females More Severely Than Males ABSTRACT Objective To characterize differences in neurologic manifestations of postacute sequelae of SARS-CoV-2 infection (Neuro-PASC) between females and males. Methods Cross-sectional study of the first...
  17. Chandelier

    Post-Acute Sequelae of COVID-19 Across 15 Major Health Domains and 67 Diseases in Individuals w/ Depressive Disorder: A Korean Cohort Study, 2026, Cho

    Post-Acute Sequelae of COVID-19 Across 15 Major Health Domains and 67 Diseases in Individuals With Depressive Disorder: A Korean Nationwide Cohort Study Abstract Background Individuals with depressive disorder often face barriers in accessing healthcare; however, research on the acute and...
  18. Chandelier

    Ozone therapy by rectal insufflation in [LC]: a preliminary study with thermographic evaluation & quality of life measurement, 2026, Sacristan Perez+

    Ozone therapy by rectal insufflation in long COVID syndrome: a preliminary study with thermographic evaluation and quality of life measurement Abstract Introduction Post-acute coronavirus disease 2019 syndrome (PACS) is a multisystemic clinical condition that clinically starting weeks or...
  19. Formerhuman

    David Putrino wants to trial Efgartigimod for a subgroup of patients with Long Covid

    At the Icahn School of Medicine at Mount Sinai, the neuroscientist and long COVID expert David Putrino is collecting blood samples from some of the patients who responded well to Vyvgart. He hopes the samples could enable better immune phenotyping so clinicians can predict whether a person with...
  20. Chandelier

    Article: Access to potential long COVID drugs dwindles as trials falter — c&en

    https://cen.acs.org/pharmaceuticals/drug-development/long-covid-pots-mecfs-drug-trials-ethics/104/web/2026/07 4000-word article. Access to potential long COVID drugs dwindles as trials falter Two sets of studies for COVID-driven conditions show the struggles of drug development by Rowan Walrath...
Back
Top Bottom